Sofinnova Investments, Inc. has filed its 13F form on November 13, 2024 for Q3 2024 where it was disclosed a total value porftolio of $1.06 Billion distributed in 62 stocks.
Among their holdings, we can observe that their the top five positions include companies like: Natera, Inc. with a value of $197M, Vera Therapeutics, Inc. with a value of $123M, Novo Nordisk A S with a value of $86.5M, Astrazeneca PLC with a value of $63.1M, and Ideaya Biosciences, Inc. with a value of $55.4M.
Examining the 13F form we can see an decrease of $745M in the current position value, from $1.8B to 1.06B.
Sofinnova Investments, Inc. is based out at Menlo Park, CA
Below you can find more details about Sofinnova Investments, Inc. portfolio as well as his latest detailed transactions.
